• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ron受体酪氨酸激酶:炎症和癌症进展的关键调节因子。

The ron receptor tyrosine kinase: a key regulator of inflammation and cancer progression.

作者信息

Wang Xin, Hankey Pamela A

机构信息

Graduate Program in Cell and Developmental Biology, The Pennsylvania State University, University Park, Pennsylvania.

出版信息

Crit Rev Immunol. 2013;33(6):549-74. doi: 10.1615/critrevimmunol.2013007953.

DOI:10.1615/critrevimmunol.2013007953
PMID:24266348
Abstract

Numerous studies have documented abnormal expression and activation of the Ron receptor tyrosine kinase in a variety of human malignancies. Here we review the literature regarding the molecular mechanisms governing Ron regulation, the biological functions of Ron, the effect of Ron on cancer development, and potential therapeutic implications. In epithelial cells, activation of Ron by its ligand, macrophage stimulating protein, mediates a number of biological events including cell growth, motility, and epithelial to mesenchymal transition. Overexpression and/or activation of Ron has been implicated in the progression and metastasis of diverse epithelial cancers, where it plays a causal role in tumor development by promoting growth, survival, and motility of tumor cells. As a crucial regulator of inflammation, Ron inhibits classic macrophage activation and promotes alternative activation of macrophages, resulting in the resolution of inflammation and tissue repair. In addition, Ron alleviates antitumor immunity by promoting the alternative activation of tumor-associated macrophages, and Ron expression in the tumor microenvironment promotes the outgrowth of metastatic colonies. Hence, Ron is a promising therapeutic target for the treatment of epithelial cancers.

摘要

众多研究已证明,Ron受体酪氨酸激酶在多种人类恶性肿瘤中存在异常表达和激活。在此,我们综述了有关Ron调控的分子机制、Ron的生物学功能、Ron对癌症发展的影响以及潜在治疗意义的文献。在上皮细胞中,Ron被其配体巨噬细胞刺激蛋白激活后,介导一系列生物学事件,包括细胞生长、运动以及上皮向间充质转化。Ron的过表达和/或激活与多种上皮癌的进展和转移有关,它通过促进肿瘤细胞的生长、存活和运动,在肿瘤发展中起到因果作用。作为炎症的关键调节因子,Ron抑制经典巨噬细胞激活并促进巨噬细胞的替代性激活,从而导致炎症消退和组织修复。此外,Ron通过促进肿瘤相关巨噬细胞的替代性激活来减轻抗肿瘤免疫,肿瘤微环境中的Ron表达促进转移菌落的生长。因此,Ron是治疗上皮癌的一个有前景的治疗靶点。

相似文献

1
The ron receptor tyrosine kinase: a key regulator of inflammation and cancer progression.Ron受体酪氨酸激酶:炎症和癌症进展的关键调节因子。
Crit Rev Immunol. 2013;33(6):549-74. doi: 10.1615/critrevimmunol.2013007953.
2
Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression.前列腺上皮细胞中的RON信号传导促进M2巨噬细胞活化,从而推动前列腺肿瘤的生长和进展。
Mol Cancer Res. 2020 Aug;18(8):1244-1254. doi: 10.1158/1541-7786.MCR-20-0060. Epub 2020 May 21.
3
Altered expression of the RON receptor tyrosine kinase in various epithelial cancers and its contribution to tumourigenic phenotypes in thyroid cancer cells.RON受体酪氨酸激酶在各种上皮性癌中的表达改变及其对甲状腺癌细胞致瘤表型的作用。
J Pathol. 2007 Dec;213(4):402-11. doi: 10.1002/path.2245.
4
Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.与Met相关的受体酪氨酸激酶Ron在肿瘤生长和转移中的作用
Adv Cancer Res. 2008;100:1-33. doi: 10.1016/S0065-230X(08)00001-8.
5
The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression.巨噬细胞刺激蛋白/Ron 通路作为一个潜在的治疗靶点,可抑制乳腺癌进展中涉及的多种机制。
Curr Drug Targets. 2010 Sep;11(9):1157-68. doi: 10.2174/138945010792006825.
6
Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase.Ron 受体酪氨酸激酶对巨噬细胞精氨酸酶表达和肿瘤生长的调控。
J Immunol. 2011 Sep 1;187(5):2181-92. doi: 10.4049/jimmunol.1003460. Epub 2011 Aug 1.
7
Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.RON受体酪氨酸激酶的肿瘤发生:恶性上皮性癌的分子靶点
Acta Pharmacol Sin. 2006 Jun;27(6):641-50. doi: 10.1111/j.1745-7254.2006.00361.x.
8
Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.人巨噬细胞刺激蛋白受体RON受体酪氨酸激酶的致癌和侵袭潜能
Carcinogenesis. 2003 Aug;24(8):1291-300. doi: 10.1093/carcin/bgg089. Epub 2003 May 22.
9
Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.巨噬细胞刺激蛋白与转化生长因子-β1 在诱导上皮-间质转化中的协同作用:RON 受体酪氨酸激酶的作用
Oncogene. 2004 Mar 4;23(9):1668-80. doi: 10.1038/sj.onc.1207282.
10
Oncogenic signaling pathways activated by RON receptor tyrosine kinase.由RON受体酪氨酸激酶激活的致癌信号通路。
Curr Cancer Drug Targets. 2003 Feb;3(1):31-40. doi: 10.2174/1568009033333745.

引用本文的文献

1
RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets.RON 在肝胆胰腺肿瘤中的作用:发病机制与潜在治疗靶点。
World J Gastroenterol. 2021 May 28;27(20):2507-2520. doi: 10.3748/wjg.v27.i20.2507.
2
Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth .小分子抑制剂瑞戈非尼可抑制神经母细胞瘤细胞中的RET信号传导,并有效抑制肿瘤生长。
Oncotarget. 2017 Oct 24;8(61):104090-104103. doi: 10.18632/oncotarget.22011. eCollection 2017 Nov 28.
3
A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells.
RON酪氨酸激酶受体的一种新型蛋白质异构体可转化人胰腺导管上皮细胞。
Oncogene. 2016 Jun 23;35(25):3249-59. doi: 10.1038/onc.2015.384. Epub 2015 Oct 19.
4
Targeting cancer with kinase inhibitors.用激酶抑制剂靶向治疗癌症。
J Clin Invest. 2015 May;125(5):1780-9. doi: 10.1172/JCI76094. Epub 2015 May 1.
5
Multiplexed protein profiling after aneurysmal subarachnoid hemorrhage: characterization of differential expression patterns in cerebral vasospasm.动脉瘤性蛛网膜下腔出血后的多重蛋白质谱分析:脑血管痉挛中差异表达模式的特征
J Clin Neurosci. 2014 Dec;21(12):2135-2139. doi: 10.1016/j.jocn.2014.06.004. Epub 2014 Jul 28.